CN1235513A - 与幽门螺杆菌及其疫苗组合物有关的核酸和氨基酸序列 - Google Patents

与幽门螺杆菌及其疫苗组合物有关的核酸和氨基酸序列 Download PDF

Info

Publication number
CN1235513A
CN1235513A CN97199233A CN97199233A CN1235513A CN 1235513 A CN1235513 A CN 1235513A CN 97199233 A CN97199233 A CN 97199233A CN 97199233 A CN97199233 A CN 97199233A CN 1235513 A CN1235513 A CN 1235513A
Authority
CN
China
Prior art keywords
seq
helicobacter pylori
polypeptide
nucleic acid
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN97199233A
Other languages
English (en)
Chinese (zh)
Inventor
D·史密斯
R·A·阿尔姆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Publication of CN1235513A publication Critical patent/CN1235513A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN97199233A 1996-10-28 1997-10-28 与幽门螺杆菌及其疫苗组合物有关的核酸和氨基酸序列 Pending CN1235513A (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US73915096A 1996-10-28 1996-10-28
US08/739,150 1996-10-28
US75973996A 1996-12-06 1996-12-06
US08/759,739 1996-12-06
US89192897A 1997-07-14 1997-07-14
US08/891,928 1997-07-14

Publications (1)

Publication Number Publication Date
CN1235513A true CN1235513A (zh) 1999-11-17

Family

ID=27419246

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97199233A Pending CN1235513A (zh) 1996-10-28 1997-10-28 与幽门螺杆菌及其疫苗组合物有关的核酸和氨基酸序列

Country Status (19)

Country Link
EP (1) EP0973394A4 (id)
JP (1) JP2001504329A (id)
KR (1) KR20000052831A (id)
CN (1) CN1235513A (id)
AR (1) AR009600A1 (id)
AU (1) AU734052B2 (id)
BR (1) BR9712587A (id)
CA (1) CA2265523A1 (id)
EE (1) EE9900176A (id)
ID (1) ID22065A (id)
IL (1) IL129397A0 (id)
IS (1) IS5005A (id)
NO (1) NO991995L (id)
NZ (1) NZ334568A (id)
PL (1) PL333169A1 (id)
SA (1) SA98180918A (id)
SK (1) SK34699A3 (id)
TR (1) TR199900940T2 (id)
WO (1) WO1998018323A1 (id)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115581201A (zh) * 2022-08-26 2023-01-10 云南省农业科学院花卉研究所 以茎段为外植体诱导的二倍体月季f1-61的植株再生方法

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3919812B2 (ja) * 1993-07-27 2007-05-30 シーエスエル、リミテッド Ｈ．ピロリ関連胃十二指腸疾患の治療
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
DE19730425A1 (de) 1997-07-16 1999-01-21 Henkel Teroson Gmbh Heißhärtende wäschefeste Rohbau-Versiegelung
AU4793499A (en) * 1998-07-27 2000-02-21 Aventis Pasteur Limited (chlamydia) antigens and corresponding dna fragments and uses thereof
SE9901548D0 (sv) * 1999-04-29 1999-04-29 Astra Ab Helicobacter pylori antigens
GB9914945D0 (en) * 1999-06-25 1999-08-25 Smithkline Beecham Biolog Novel compounds
AUPQ347199A0 (en) * 1999-10-15 1999-11-11 Csl Limited Novel polypeptide fragments
EP1263942B1 (en) 2000-03-08 2013-11-06 Novozymes A/S Variants with altered properties
GB0010371D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
GB0010370D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
JP6078865B2 (ja) * 2011-03-17 2017-02-15 国立大学法人三重大学 抗体の製造方法
CN108495650B (zh) * 2015-12-14 2026-04-21 慕尼黑工业大学 幽门螺杆菌疫苗
CN115724922B (zh) * 2022-07-19 2023-08-22 四川大学华西医院 一种幽门螺杆菌疫苗重组蛋白抗原TonB及其制备方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9300139L (sv) * 1993-01-19 1994-07-20 Medicarb Ab Framställning av ett nytt läkemedel

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115581201A (zh) * 2022-08-26 2023-01-10 云南省农业科学院花卉研究所 以茎段为外植体诱导的二倍体月季f1-61的植株再生方法

Also Published As

Publication number Publication date
WO1998018323A1 (en) 1998-05-07
TR199900940T2 (xx) 1999-09-21
NO991995D0 (no) 1999-04-27
IL129397A0 (en) 2000-02-17
EE9900176A (et) 1999-12-15
BR9712587A (pt) 1999-10-26
JP2001504329A (ja) 2001-04-03
KR20000052831A (ko) 2000-08-25
EP0973394A4 (en) 2005-03-30
SK34699A3 (en) 2000-04-10
AU5093398A (en) 1998-05-22
AU734052B2 (en) 2001-05-31
SA98180918A (ar) 2005-12-03
AR009600A1 (es) 2000-04-26
CA2265523A1 (en) 1998-05-07
NO991995L (no) 1999-06-28
ID22065A (id) 1999-08-26
IS5005A (is) 1999-03-18
EP0973394A1 (en) 2000-01-26
NZ334568A (en) 2000-04-28
PL333169A1 (en) 1999-11-22

Similar Documents

Publication Publication Date Title
CN1117149C (zh) 用于免疫治疗和诊断结核病的化合物和方法
JP5349448B2 (ja) Ｐ．ｇｉｎｇｉｖａｌｉｓ抗原組成物
CN1280619A (zh) 沙眼衣原体的基因组序列和多肽,其片段以及其用途,特别是用于诊断、预防和治疗感染
CN1597694A (zh) 脑膜炎奈瑟氏球菌抗原
CN1636062A (zh) 编码多肽抗原的新肺炎链球菌可读框及其应用
CN1437653A (zh) 抗原多肽
CN1279717A (zh) 肺炎衣原体的基因组序列和其多肽、片段以及其用途特别是用于诊断、预防和治疗感染
CN1176658A (zh) 治疗和预防艰难梭菌疾病的疫苗和抗毒素
CN1263436A (zh) 在螺杆菌属基因组中鉴定编码新型螺杆菌属多肽的多核苷酸
CN1235555A (zh) 治疗和诊断分枝杆菌感染的化合物和方法
CN1192241A (zh) Hsp70家族的链球菌热休克蛋白
WO1998059071A1 (en) Lyme disease vaccines
HK1045856A1 (zh) 抗细菌疫苗组合物
CN1294632A (zh) 得自母牛分枝杆菌的组合物及其使用方法
CA2249746C (en) Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
CN1246799A (zh) 关于幽门螺杆菌的核酸序列和氨基酸序列及其疫苗组合物
CN1220703A (zh) 与幽门螺杆菌及其疫备组合物有关的核酸和氨基酸序列
SK34699A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
CA2516971A1 (en) Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof
CN1275164A (zh) 奈瑟氏球菌乳铁蛋白结合蛋白
CN1331699A (zh) 鉴定抗原基因序列的方法
CN1198931C (zh) 粘膜炎莫拉氏菌basb034多肽及应用
CN1210401C (zh) 源自粘膜炎莫拉氏菌的化合物
CN1357045A (zh) 外表面蛋白质及其基因和用途
CN1371389A (zh) 疫苗

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication